#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.
RSS   Newsletter   Contact   Advertise with us

Teva Pharmaceutical Q4 earnings $683 million

Share on Twitter Share on LinkedIn
Christian Fernsby ▼ | February 12, 2020
Teva Pharmaceutical posted fourth quarter adjusted earnings of $683 million vs. $543 million in the comparable year earlier period.
Teva Pharmaceutical USA
Teva Pharmaceutical   Total sales were $4.47 billion for the quarter
Total sales were $4.47 billion for the quarter, above the $4.42 billion it brought in a year ago and above analysts’ estimates of $4.36 billion.

Topics: Teva Pharmaceutical

Sales of its multiple sclerosis drug Copaxone came in at $387 million, above estimates of $352.8 million, while sales of Austedo, used to treat Huntington’s disease and tardive dyskinesia, came in at $136 million vs. estimates of $111.8 million.


 

MORE INSIDE POST